Dodecaborate cluster lipids with variable headgroups for boron neutron capture therapy: Synthesis, physical-chemical properties and toxicity

Journal of Organometallic Chemistry

Volumn 694, Issue 11, 2009, Pages 1708-1712

  Schaffran, Tanja ^a   Lissel, Franziska ^a   Samatanga, Brighton ^b   Karlsson, Göran ^c   Burghardt, Alexander ^d   Edwards, Katarina ^c   Winterhalter, Mathias ^b   Peschka Süss, Regine ^d   Schubert, Rolf ^d   Gabel, Detlef ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b JACOBS UNIVERSITY BREMEN   (Germany)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Boron cluster; Boron neutron capture therapy; Lipid; Liposome; Toxicity

Indexed keywords

AMINATION; AMINES; BORON; BUTENES; DERIVATIVES; ESTERS; ETHERS; LIPOSOMES; NEUTRONS; NONMETALS; PHOSPHOLIPIDS; SYNTHESIS (CHEMICAL); TOXICITY;

BI LAYERS; BORON CLUSTER; BORON NEUTRON CAPTURE THERAPY; BORON-CONTAINING; DIETHANOLAMINE; HEAD GROUPS; HIGH TEMPERATURES; IN-VITRO; IN-VIVO; MELTING TRANSITIONS; NUCLEOPHILIC ATTACKS; TETRAHYDROFURANE; THERMOTROPIC BEHAVIORS;

BORON COMPOUNDS;

EID: 63249132829     PISSN: 0022328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jorganchem.2008.12.044     Document Type: Article

References (23)

1. Alam F., Barth R.F., and Soloway A.H. Antibody Immunoconjug. Radiopharm. 2 (1989) 145
2. Schinazi R.F., and Prusoff W.H. Tetrahedron Lett. 50 (1978) 4981
3. Miura M., Gabel D., Fairchild R.G., Laster B.H., and Warkentien L.S. Strahlenther. Onkol. 165 (1989) 131
4. Kahl, and Koo M.-S. Chem. Commun. (1990) 1769
5. Pathak A.P., Artemov D., Ward B.D., Jackson D.G., Neeman M., and Bhujwalla Z.M. Cancer Res. 65 (2005) 1425
6. Dreher M.R., Liu W., Michelich C.R., Dewhirst M.W., Yuan F., and Chilkoti A. J. Natl.Cancer Inst. 98 (2006) 335
7. Mehta S.C., Lai J.C., and Lu D.R. J. Microencapsul. 13 (1996) 269
8. Johnsson M., Bergstrand N., and Edwards K. J. Liposome Res. 9 (1999) 53
9. Maruyama K., Ishida O., Kasaoka S., Takizawa T., Utoguchi N., Shinohara A., Chiba M., Kobayashi H., Eriguchi M., and Yanagie H.J. Control Release 98 (2004) 195
10. Gabel D., Awad D., Schaffran T., Radovan D., Daraban D., Damian L., Winterhalter M., Karlsson G., and Edwards K. ChemMedChem 2 (2007) 51
11. Lemmen P., Weißfloch L., Auberger T., and Probst T. Anticancer Drugs 6 (1995) 744
12. Nakamura H., Miyajima Y., Takei T., Kasaoka S., and Maruyama K. Chem. Commun. (2004) 1910
13. Miyajima Y., Nakamura H., Kuwata Y., Lee J.D., Masunaga S., Ono K., and Maruyama K. Bioconjug. Chem. 17 (2006) 1314
14. Li T., Hamdi J., and Hawthorne M.F. Bioconjug. Chem. 17 (2006) 15
15. Lee J.-D., Ueno M., Miyajima M.Y., and Nakamura H. Org. Lett. 9 (2006) 323
16. Nakamura H., Lee J.D., Ueno M., Miyajima Y., and Ban H.S. Nanobiotechnology 3 (2007) 135
17. Justus E., Awad D., Hohnholt M., Schaffran T., Edwards K., Karlsson G., Damian L., and Gabel D. Bioconjug. Chem. 18 (2007) 1287
18. Sivaev I.B., Kulikova N.Yu., Nizhnik E.N., Vichuzhanin M.V., Starikova Z.A., Semioshkin A.A., and Bregadze V.I. J. Organomet. Chem. 693 (2008) 519
19. Stewart J.C. Anal. Biochem. 104 (1980) 10
20. Semioshkin A., Nizhnik E., Godovikov I., Starikova Z., and Bregadze V. J. Organomet. Chem. 692 (2007) 4020
21. Silvius J.R. Biochim. Biophys. Acta 857 (1986) 217
22. Ipsen J.H., Mouritsen O.G., and Bloom M. Biophys. J. 57 (1990) 405
23. Ishida O., Maruyama K., Tanahashi H., Iwatsuru M., Sasaki K., Eriguchi M., and Yanagie H. Pharm. Res. 18 (2001) 831